BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25982683)

  • 1. Identifying novel biomarkers of gastric cancer through integration analysis of single nucleotide polymorphisms and gene expression profile.
    Wang T; Xu Y; Hou P
    Int J Biol Markers; 2015 Jul; 30(3):e321-6. PubMed ID: 25982683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of differently expressed genes with specific SNP Loci for breast cancer by the integration of SNP and gene expression profiling analyses.
    Yuan P; Liu D; Deng M; Liu J; Wang J; Zhang L; Liu Q; Zhang T; Chen Y; Jin G
    Pathol Oncol Res; 2015 Apr; 21(2):469-75. PubMed ID: 25408372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of significant biomarkers and pathways associated with gastric carcinogenesis by whole genome-wide expression profiling analysis.
    Fei HJ; Chen SC; Zhang JY; Li SY; Zhang LL; Chen YY; Chang CX; Xu CM
    Int J Oncol; 2018 Mar; 52(3):955-966. PubMed ID: 29328368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of biomarkers for diagnosis of gastric cancer by bioinformatics.
    Wang DG; Chen G; Wen XY; Wang D; Cheng ZH; Sun SQ
    Asian Pac J Cancer Prev; 2015; 16(4):1361-5. PubMed ID: 25743799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analysis identifies biomarkers associated with poor prognosis in diffuse‑type gastric cancer.
    Li S; Yu C; Cheng Y; Du F; Wen G
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel prognostic biomarkers of gastric cancer based on gene expression microarray: COL12A1, GSTA3, FGA and FGG.
    Duan S; Gong B; Wang P; Huang H; Luo L; Liu F
    Mol Med Rep; 2018 Oct; 18(4):3727-3736. PubMed ID: 30106150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
    Hu C; Zhou Y; Liu C; Kang Y
    Int J Oncol; 2018 Aug; 53(2):633-643. PubMed ID: 29901187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative transcriptome analysis between metastatic and non-metastatic gastric cancer reveals potential biomarkers.
    Feng D; Ye X; Zhu Z; Wei Z; Cai Q; Wang Y
    Mol Med Rep; 2015 Jan; 11(1):386-92. PubMed ID: 25334039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide analysis of aberrant gene expression and methylation profiles reveals susceptibility genes and underlying mechanism of cervical cancer.
    Lin H; Ma Y; Wei Y; Shang H
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():147-152. PubMed ID: 27863272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of candidate target genes of pituitary adenomas based on the DNA microarray.
    Zhou W; Ma CX; Xing YZ; Yan ZY
    Mol Med Rep; 2016 Mar; 13(3):2182-6. PubMed ID: 26782791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Biomarkers for Early Diagnosis of Acute Myocardial Infarction.
    Ge WH; Lin Y; Li S; Zong X; Ge ZC
    J Cell Biochem; 2018 Jan; 119(1):650-658. PubMed ID: 28636181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis of gene expression and genomic aberration data in osteosarcoma (OS).
    Xiong Y; Wu S; Du Q; Wang A; Wang Z
    Cancer Gene Ther; 2015 Nov; 22(11):524-9. PubMed ID: 26427513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of gastric cancer.
    Jiang HB; Yang TJ; Lu P; Ma YJ
    Eur Rev Med Pharmacol Sci; 2014; 18(15):2109-15. PubMed ID: 25070814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 21‑gene Support Vector Machine classifier and a 10‑gene risk score system constructed for patients with gastric cancer.
    Jiang H; Gu J; Du J; Qi X; Qian C; Fei B
    Mol Med Rep; 2020 Jan; 21(1):347-359. PubMed ID: 31939629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying the mRNAs associated with Bladder cancer recurrence.
    Cao H; Cheng L; Yu J; Zhang Z; Luo Z; Chen D
    Cancer Biomark; 2020; 28(4):429-437. PubMed ID: 32390597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Analysis of Key Genes Driving Gastric Cancer Through Bioinformatics.
    Liu Z; Liu S; Guo J; Sun L; Wang S; Wang Y; Qiu W; Lv J
    Genet Test Mol Biomarkers; 2021 Jan; 25(1):1-11. PubMed ID: 33470887
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening of potential biomarkers in uterine leiomyomas disease via gene expression profiling analysis.
    Liu X; Liu Y; Zhao J; Liu Y
    Mol Med Rep; 2018 May; 17(5):6985-6996. PubMed ID: 29568968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional Regulatory Network Analysis for Gastric Cancer Based on mRNA Microarray.
    Wang Y
    Pathol Oncol Res; 2017 Oct; 23(4):785-791. PubMed ID: 28078605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of transcriptional factors and key genes in primary osteoporosis by DNA microarray.
    Xie W; Ji L; Zhao T; Gao P
    Med Sci Monit; 2015 May; 21():1333-44. PubMed ID: 25957414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.